Enzymatica AB Statistics

Total Valuation

Enzymatica AB has a market cap or net worth of SEK 472.12 million. The enterprise value is 440.34 million.

Market Cap	472.12M
Enterprise Value	440.34M

Important Dates

The next estimated earnings date is Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Enzymatica AB has 242.74 million shares outstanding. The number of shares has increased by 40.22% in one year.

Current Share Class	242.74M
Shares Outstanding	242.74M
Shares Change (YoY)	+40.22%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	7.00%
Owned by Institutions (%)	14.41%
Float	106.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.95
PB Ratio	3.48
P/TBV Ratio	6.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.13
EV / Sales	8.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.06

Financial Position

The company has a current ratio of 5.25, with a Debt / Equity ratio of 0.01.

Current Ratio	5.25
Quick Ratio	3.91
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-134.44

Financial Efficiency

Return on equity (ROE) is -33.30% and return on invested capital (ROIC) is -20.84%.

Return on Equity (ROE)	-33.30%
Return on Assets (ROA)	-18.98%
Return on Invested Capital (ROIC)	-20.84%
Return on Capital Employed (ROCE)	-40.37%
Revenue Per Employee	2.51M
Profits Per Employee	-2.58M
Employee Count	21
Asset Turnover	0.29
Inventory Turnover	1.26

Taxes

Income Tax	-104,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.33% in the last 52 weeks. The beta is 0.26, so Enzymatica AB's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	+19.33%
50-Day Moving Average	2.00
200-Day Moving Average	2.72
Relative Strength Index (RSI)	50.23
Average Volume (20 Days)	47,190

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Enzymatica AB had revenue of SEK 52.73 million and -54.14 million in losses. Loss per share was -0.22.

Revenue	52.73M
Gross Profit	33.62M
Operating Income	-54.85M
Pretax Income	-54.25M
Net Income	-54.14M
EBITDA	-52.23M
EBIT	-54.85M
Loss Per Share	-0.22

Full Income Statement

Balance Sheet

The company has 33.08 million in cash and 1.31 million in debt, giving a net cash position of 31.78 million or 0.13 per share.

Cash & Cash Equivalents	33.08M
Total Debt	1.31M
Net Cash	31.78M
Net Cash Per Share	0.13
Equity (Book Value)	135.68M
Book Value Per Share	0.56
Working Capital	56.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -61.99 million and capital expenditures -402,000, giving a free cash flow of -62.39 million.

Operating Cash Flow	-61.99M
Capital Expenditures	-402,000
Free Cash Flow	-62.39M
FCF Per Share	-0.26

Full Cash Flow Statement

Margins

Gross margin is 63.76%, with operating and profit margins of -104.02% and -102.68%.

Gross Margin	63.76%
Operating Margin	-104.02%
Pretax Margin	-102.88%
Profit Margin	-102.68%
EBITDA Margin	-99.05%
EBIT Margin	-104.02%
FCF Margin	n/a

Dividends & Yields

Enzymatica AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-40.22%
Shareholder Yield	-40.22%
Earnings Yield	-11.47%
FCF Yield	-13.22%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2